Exercise for Improving Long-course Chemoradiotherapy Efficacy in People With Locally Advanced Rectal Cancer

Recruiting now · Early Phase 1

Conditions studied: Locally Advanced Rectal Carcinoma

In brief

This is a single arm feasibility study of exercise for improving long- course neoadjuvant chemoradiotherapy (NACRT) efficacy in people diagnosed with locally advanced rectal cancer. The study aims to recruit up to 30 patients from the Queen's Centre for Oncology and Haematology of Castle Hill Hospital, Cottingham, diagnosed with locally advanced rectal cancer. Consenting patients will be provided with an 11-week course of structured aerobic exercises and resistance training in the periods before, during and after their chemoradiotherapy treatment. The patients will be followed up for 6 months post long course neoadjuvant chemoradiotherapy (NACRT), with a total of 3 assessment periods.

Key facts

Study ID

NCT06276686

Run by

University of Hull

People needed

30

Starts

2024-12-10

Expected to finish

2026-02-28

Last updated by the study team

2025-02-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years or older
• Have been diagnosed with locally advanced rectal cancer using MRI (Magnetic Resonance Imaging) and histological finding
• Have been offered long-course neoadjuvant chemoradiotherapy in the Queens Centre, Castle Hill Hospital
• Willing and able to comply with all study requirements
• Able and willing to voluntarily give informed consent to take part.

You may not qualify if…

• Inability to understand basic written and spoken English, as research materials will all be written in English.
• Any movement deficiencies limiting ability to engage in exercise.
• Impaired cognition and/or capacity limiting ability to provide informed consent.
• Cardiovascular and/or cardiopulmonary conditions that will impede ability to safely perform exercise.
• Severe psychiatric disorders.
• With any other health condition which oncologists and research team agrees will impede ability to safely perform exercises.
• Presence of metastatic cancer.

Where it is running

• Castle Hill Hospital — Cottingham, East Yorkshire, United Kingdom (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.